FDA Brief

Warning letters Drugs

FDA warning letter to

Ultimark Products

High riskIssued Apr 13, 2022Posted Apr 19, 2022Center for Drug Evaluation and Research | CDER

Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.

What happened

FDA reviewed the product label and labeling on Porcelana.com, where the cream is sold, and found claims that it fades dark spots and lightens skin, with hydroquinone 2% as the active ingredient. FDA determined the product is a skin-bleaching drug subject to section 505G; because FDA had proposed that OTC skin-bleaching products including hydroquinone are not generally recognized as safe and effective, the product is deemed a new drug needing an approved application. No approved application is in effect, and FDA also cites it as misbranded.

What FDA found

  1. The company sells a skin-lightening cream containing 2% hydroquinone as an unapproved new drug without an FDA-approved drug application.

    FD&C Act section 505(a), 21 U.S.C. 355(a)
  2. The product is misbranded because it is a nonprescription drug subject to section 505G but lacks an approved application and does not comply with section 505G.

    FD&C Act section 502(ee), 21 U.S.C. 352(ee); section 505G, 21 U.S.C. 355h
  3. The skin-bleaching drug is deemed a new drug because FDA proposed that OTC skin-bleaching products with hydroquinone are not generally recognized as safe and effective.

    FD&C Act section 201(p)(1); section 505G(a)(4), 21 U.S.C. 355h(a)(4)

What FDA wants

Respond in writing within 15 working days describing what you have done to correct the violations and prevent recurrence, or explain why you believe the product is not in violation. If you cannot fully address the violations in that time, state the reasons for delay and a completion schedule.

Who should pay attention

  • retailers and online marketplaces selling Porcelana or hydroquinone skin-lightening creams
  • brands and contract manufacturers making OTC skin-bleaching products
  • regulatory teams handling drug listing and OTC drug compliance

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk